Ignelzi Troy A.
Chief Financial Officer
Ignelzi Troy A. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, Ignelzi Troy A. is listed as Chief Financial Officer at Rapport Therapeutics, Inc. Inside the rolling window, Ignelzi Troy A. reported 1 open-market purchase totaling $144K in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$144K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ignelzi Troy A. made?
Ignelzi Troy A. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Ignelzi Troy A. trade?
Ignelzi Troy A. has filed SEC Form 4 disclosures for 1 company, including RAPP.
When was Ignelzi Troy A.'s most recent SEC Form 4 filing?
Ignelzi Troy A.'s most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is Ignelzi Troy A.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ignelzi Troy A. is listed as Chief Financial Officer.
What is Ignelzi Troy A.'s total buy and sell value in the current window?
Inside the rolling retention window, Ignelzi Troy A. bought $144K and sold $0 based on SEC Form 4 filings.
What was Ignelzi Troy A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,500 RAPP shares on 2026-10-21, worth $144K, per SEC Form 4 filings.